SEC Form 4 · accession 0001209191-17-061052
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Hochman
Director
Period of report
Nov 15, 2017
Accepted (ET)
Nov 16, 2017 · 8:54 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 15, 2017 | P | 5,000 | $6.55 | A | 220,000 | I | By NSH 2008 Family Trust |
| Common Stock | holding | — | — | — | 459,500 | D | ||
| Common Stock | holding | — | — | — | 4,300 | I | By Solomon Asher Hochman Trust of 2005 | |
| Common Stock | holding | — | — | — | 4,300 | I | By Hannah Hochman Trust of 2007 | |
| Common Stock | holding | — | — | — | 4,300 | I | By Judah Herman Hochman Trust of 2009 |
Table II — derivative securities
No Table II lines on this filing.